期刊文献+

幼年特发性关节炎患者外周血单个核细胞中miR-21miR-19a与JA刚STAT通路的表达与意义 被引量:4

The expression level and value of miR-21, miR-19a and JAK/STAT pathway in peripheral monocytes of juvenile idiopathic arthritis
原文传递
导出
摘要 目的探讨miR-21、miR-19a在幼年特发性关节炎(JIA)发病中的作用及与JAK/STAT通路关键靶基因(SOCS3、STAT3)的相互关系。方法收集广州市妇女儿童医疗中心确诊的33例活动期JIA患儿(病例组,其中全身型组20例,关节型组13例);健康对照组20名。Fieoll法分离PBMCs,提取和纯化miRNA,反转录为cDNA;通过Targetscan和RNA22共同预测靶基因,设计引物,miR-21、miR-19a以u6为内参,STAT3、SOCS3、IL-6、TNF-α mRNA以β肌动蛋白为内参,应用荧光定量PCR分别检测其组间表达,计算标准化后的2^-△△CT值表示miRNA的相对表达含量,非参数检验统计2组数据2^-△△CT的差异。结果病例组与对照组miR-21表达水平低于对照组,差异有统计学意义(Z=2.11,P=0.036);其中,对照组miR-21相对表达量为全身型组的7.7(7~8.5)倍、关节型的6.49(6~7)倍,差异有统计学意义(Z=2.615,P=0.0149;Z=2.654,P=0.0291);全身型组与关节型组间miR-21表达水平差异无统计学意义(Z=0.221,P=0.8271)。病例组与对照组miR-19a表达水平低于对照组,差异有统计学意义(Z=2.41,P=0.014);其中,对照组miR-19a相对表达量为全身型组的11.3(10-12.1)倍、关节型的12.2(12~13.5)倍,差异有统计学意义(Z=2.334,P=0.0157;Z=2.414,P=0.0266);全身型组与关节型组间miR-19a表达水平差异无统计学意义(Z=O.538,P=O.596)。软件预测显示与JAK/STAT通路相关的STAT3,SOCS3、TNF—α分别为miR.21、mill-19a的靶基因。荧光定量PCR示病例组(全身型组、关节型组)STAT3[6.24(2.81,7.54)与3.97(1.81,5.75),P=0.001,0.008j、TNF-α[3.03(2.07,3.80)与3.42(2.46,4.68),P=0.002,0.001]、IL-6[4.75(3.59,6.32)与3.52(2.31,7.51),P=0.006,0.036]、SOCS3p2.54(1.77,4.00)与3.57(1.95,3.83),P=0.003,0.001[mRNA相对表达量较对照组高;病例组(全身型组、关节型组)STAT3mRNA相对表达量与miR-21呈负相关(r=-O.5854,P=0.0067;r=-0.6134,P=0.0447),病例组(全身型组、关节型组)TNF-α、SOCS3mRNA相对表达量与miR-19a呈现负相关,全身型组TNF.d(r=-0.6642,P=0.0014)、SOTS3(r=-0.7903,P=0.0001)。关节型组TNF-α(r=-0.6261,P=0.0393)、SOCS3(r=-0.8824,P=0.003)。结论JIA患者与健康人相比,PBMCs中miR-21、miR-19a表达水平的降低,其靶基因STAT3、SOCS3、TNF-α mRNA表达升高,提示JAK/STAT通路激活,miR-21、mill-19a水平降低与该通路的激活有关。 Objective To explore the expression of miR-21 and miR-19a in juvenile idiopathic arthritis (JIA) and the relationship among the key target genes (SOCS3, STAT3) in JAK/STAT pathways. Methods The venous blood from 33 cases of active JIA in Guangzhou Women and Children Medical Center were collected. All cases were divided into two groups: the systemic group (n=20), polyarthritis group (n=13).Twenty subjects were used as the normal control group. Peripheral blood mononuclear cells (PBMCs) were extracted and separated with Ficoll. miRNA was extracted and purified and real-time quantitative polymerase chain reaction (RT-PCR) was used to obtain cDNA. Target genes of miRNA were detected through Targetscan and RNA22. U6 was used for reference of miR-19a, miR-21 and β-actin were used for STAT3, SOCS3, IL-6, TNF-α mRNA. All the expression were detected by fluorescence quantitative PCR among the groups and calculated the result in standardized 2^-△△CT value, non-parametric test was used to test the differences. Results The expression of miR-2l were significantly reduced in the case group than the control group (Z=2.11, P= 0.036), in which miR-21 was 7(7-8.5) times reduced than the SJIA group, 6.49 (6-7) times than the pJIA group, the difference was statistically significant (Z=2.615, P=0.014 9; Z=2.654, P=0.0291). But no significant difference of miR-21 expression could be found between the SJIA and PJIA groups (Z=0.221, P =0.827 1). The expression of miR-19a was significantly reduced in the case group than the control group (Z=2.41, P=0.014), in which miR-19a was 11.3 (10-12.1) times to the SJIA group, 12.2 (12-13.5) times to the pJIA group, the difference was statistically significant (Z=2.334, P=0.015 7; Z=2.414, P=0.026 6). But no significant difference could be detected in the miR-21 expression between the SJIA and the PJIA groups (Z=0.538, P=0.596). Software estimated that STAT3, SOCS3, TNF-α were the target genes of miR-21 and miR-19a in the JAK/STAT pathways respectively. Fluorescence quantitative PCR had shown that mRNA expression of STAT3 [6.24(2.81, 7.54) and 3.97(1.81, 5.75), P=0.001, 0.008], TNF-α [3.03(2.07, 3.80) and 3.42(2.46, 4.68), P=0.002, 0.001], IL-6[4.75(3.59, 6.32) and 3.52(2.31, 7.51), P=0.006, 0.036], SOCS312.54(1.77, 4.00) and 3.57(1.95, 3.83), P= 0.003, 0.001] was higher in the case Group (SJIA group, the PJIA group) than the control group; STAT3 mRNA expression was negatively correlated with the miR-21 (r=-0.585 4, P=0.006 7; r=-0.613 4, P=0.044 7) and there was statistically significant difference. TNF-α, SOCS3 mRNA expression in the case group (SJIA group, PJIA group) was negatively correlated with the miR-19a. TNF-α (r=-0.664 2, P=0.001 4), SOCS3 (r=-0.790 3, P=0.000 1) of the SJIA group,was higher than those of the PJIA group TNF-α (r=-0.626 1, P=0.039 3), SOCS3 (r=-0.8824,/)--0.003), the difference was significant. Conclusion The expression of miR-21, miR-19a in PBMC in the JIA patients are lower than the control group. The high expression of the target genes, miR-21, miR-19a of STAT3, SOCS3, TNF-a suggest that these genes might associate with, activating of JAK/STAT pathway.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2016年第7期459-464,共6页 Chinese Journal of Rheumatology
基金 广东省科技计划项目(2014A020212010)
关键词 关节炎 幼年型类风湿 miRNA JAK/STAT 信号通路 Arthritis, juvenile rheumatoid miRNA JAK/STAT signaling pathways
  • 相关文献

参考文献24

  • 1Beukelman T. Treatment advances in systemic juvenile idiopathic arthritis[J]. F100OPrime Rep, 2014, 1(6): 21. DOI: 10.12703/ P6-21.
  • 2Roderburg C, Luedde T. Circulating microRNAs as markers of liver inflammation, fibrosis and cancer[J]. J Hepatol, 2014, 61 (6): 1434-1437. DOI: 10.1016/j.jhep.
  • 3Kurowska-Stolarska M, Alivernini S, Ballantine LE, et al. Mi- croRNA-155 as a proinflammatory regulator in clinical and ex- perimental arthritis[J]. Proc Natl Acad Sci USA, 2011, 108 (27): 11193-11198. DOI: 10.1073/pnas.
  • 4Zhou Q, Haupt S, Kreuzer JT, et al. Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg pheno- type in patients with rheumatoid arthritis[J]. Ann Rheum Dis, 2015, 74: 1265-1274. DOI: 10.1136/annrheumdis-2013-204377.
  • 5Xie Q, Wang SC, Zhong J, et al. MicroRNA-146a, a good biomarker and potential therapeutic target for rheumatoid arthritis [J]. Genet Test Mol Biomarkers, 2013, 17(2): 91-92. DOI: 10. 1089/gtmb.2012.0333.
  • 6Long L, Yu P, Liu Y, et al. Upregulated microRNA-155 expres- sion in peripheral blood mononuclear cells and fibroblast-like synoviocytes in rheumatoid arthritis[J]. Clin Dev Immunol, 2013, 2013(2013) : 296139. DOI: 10.1155/2013/296139.
  • 7Chen SY. MicroRNA-223: a double-edged sword in rheumatoid arthritis[J]. Rheumatol Int, 2014, 34(2): 285-286. DOI: 10. 1007/s00296-013-2720-5.
  • 8Sawant DV, Wu H, Kaplan MH, et al. The Bcl6 target gene mi-croRNA-21 promotes Th2 differentiation by a T cell intrinsic pathway[J]. Mol Innnunol, 2013, 54(3/4): 435-442. DOI: 10. 1016/j.molimm.2013.01.006.
  • 9Shibuya H, Nakasa T, Adachi N, et al. Overexpression of mi- croRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation[J]. Mod Rheumatol, 2013, 23(4): 674-685. DOI: 10.1007/s10165-012-0710-1.
  • 10Jimenez-Morales, S Gamboa-Becerra, Baca R, et al. MiR-146a polymorphism is associated with asthma but not with systemic lupus erythematosus and juvenile rheumatoid arthritis in Mexican patients[J]. Tissue Antigens, 2012, 80(4): 317-321. DOI: 10. 1111/j. 1399-0039.2012.01929.

二级参考文献4

共引文献4

同被引文献18

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部